Novo Nordisk A/S NVO Price Prediction & Forecast



Forecast

NVO Stock Price Prediction

Novo Nordisk A/S

$46.4

0.71%

$0.32

At close: May 11, 16:00:00 GMT-4

$46.3

-0.2%

$-0.09

Post-market: May 11, 16:47:58 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$46.07

Open

$46.69

Day's Range

$46.27 - $47.79

52 week range

$35.12 - $81.44

Volume

17.7M

Avg.Volume

21.1M

Dividend yield

EPS (TTM)

3.61

Market Cap

$155.5B

What is Novo Nordisk A/S?

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Features

Markets

News

According to analyst forecasts, we anticipate notable price fluctuations for NVO in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $51.53. The lowest target is $28.27 and the highest is $74.56. Empower your investment choices with our cutting-edge, data-driven analysis!

NVO Stock Price Prediction Summary

Top Analyst Ratings for NVO

Based on 30 analysts giving stock ratings to NVO, updated on Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NVO. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NVO is a Buy candidate.

NVO stock price ended at $46.07 on Friday, after rising 0.59%

On the latest trading day May 08, 2026, the stock price of NVO rose by 0.59%, climbing from $45.97 to $46.07. Throughout the session, the stock experienced a volatility of 2.10%, with prices fluctuating between a daily low of $45.19 and a high of $46.14. Alongside this price increase, trading volume also rose by 4.8M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 12.0M shares were traded, amounting to a market value of approximately $154.7B.

NVO Technical Signals

Technical Signals Summary

Buy Signals 4

Neutral Signals 0

Sell Signals 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

NVO currently exhibits 4 buy signals and 3 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 14.35% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.

Bullish/Bearish Signals for NVO

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NVO. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to NVO?



According to technical analysis, Novo Nordisk A/S has an aggregate signal of Buy. Novo Nordisk A/S has 4 Buy signals, 0 Neutral Signals and 3 sell signals.

What are the Fibonacci retracement levels for NVO?



The Fibonacci retracement level for Novo Nordisk A/S is between 23.6% and 38.2%

What is the RSI for Novo Nordisk A/S?



The RSI for Novo Nordisk A/S is currently 83.91, indicating a overbought condition

What is Novo Nordisk A/S price for the next 12 months?



Novo Nordisk A/S NVO price for the next 12 months is estimated at $51.53.

How high is Novo Nordisk A/S expected to go?



According to wall street analysts, Novo Nordisk A/S is expected to reach a high forecast of $74.56.

Novo Nordisk A/S (NVO) Stock Price Prediction

NVO Stock Price Chart